Search | TVST | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles December 2020

Alginate- and Hyaluronic Acid–Based Hydrogels as Vitreous Substitutes: An In Vitro Evaluation

PDF

André Schulz; Annekatrin Rickmann; Silke Wahl; Anja Germann; Boris Viktor Stanzel; Kai Januschowski; Peter Szurman

Trans. Vis. Sci. Tech.. 2020; 9(13):34. https://doi.org/10.1167/tvst.9.13.34

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Lisa Pohl; Nele Heider; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Kai Januschowski; Sven Schnichels; Martin Spitzer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6608.

ARVO Annual Meeting Abstract July 2018

Hyaluronic acid based cross-linked hydrogels – a biosafe, sufficient tamponade of the vitreous body

Lisa Katharina Pohl; Kai Januschowski; Sven Schnichels; Jose Hurst; Christine Hohenadl; Charlotte Reither; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5931.

ARVO Annual Meeting Abstract June 2017

Pilot Data on Monitoring Objective Compliance with Intermittent Occlusion Glasses Therapy

Jingyun Wang; Kai Januschowski; Charlotte Schramm; Daniel E Neely

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2358.

ARVO Annual Meeting Abstract June 2017

Efficacy of two different thiol-modified crosslinked hyaluronate formulations compared to silicone oil in a model of retinal detachment

Martin Stephan Spitzer; Nele Schneider; Jose Hurst; Christine Hohenadl; Kai Januschowski; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4174.

ARVO Annual Meeting Abstract September 2016

Suprachoroidal hydrogel buckling as a surgical treatment of retinal detachment - biocompatibility and first experiences

Kai Januschowski; Karl Boden; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1036.

ARVO Annual Meeting Abstract September 2016

Comparison of optic nerve head analysis in patients with glaucomatous optic neuropathy between the simultaneous stereoscopic photography retinal camera (Kowa nonmyd WX3D) and the confocal scanning laser ophthalmoscope (HRT III)

Siegfried Mariacher; Stephanie Hipp; Robert Whirtky; Gunnar Blumenstock; Karl Ulrich Bartz-Schmidt; Focke Ziemssen; Ulrich Schiefer; Bogomil Voykov; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):836.

ARVO Annual Meeting Abstract September 2016

Novel thixotropic silicone oils – the ketchup bottle approach for trocar-guided vitrectomy

Christian Klameth; Christian Lingenfelder; Christoph Lindner; Berenike Kunzmann; Kai Januschowski; Karl-Ulrich Bartz-Schmidt; Max Schultheiss; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4477.

ARVO Annual Meeting Abstract June 2015

Toxic Effects of Melphalan on Retinal Pigment Epithelial Cells

Sabine Aisenbrey; Ulrike Hagemann; Merle Schrader; Kai Januschowski; Sven Schnichels; Daniela Suesskind

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):77.

ARVO Annual Meeting Abstract June 2015

A minimal invasive implantable sensor for telemetric intraocular pressure monitoring

Siegfried Mariacher; Martina Ebner; Kai Januschowski; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):109.

ARVO Annual Meeting Abstract June 2015

An ex-vivo model for the short term IOP development for vitreous tamponades

Kai Januschowski; Siegfried Mariacher; Martina Ebner; sven schnichels; jose hurst; Peter Szurman; Karl Ulrich Bartz-Schmidt; Martin Stephan Spitzer; Johanna Hofmann, Lisa Pohl, Nele Schneider,

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):211.

ARVO Annual Meeting Abstract June 2015

Problems in occlusion therapy - a qualitative study with parents and educators

Charlotte Schramm; Sybille Gräf; Natalia Radionova; Monika A Rieger; Dorothea Besch; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2189.

ARVO Annual Meeting Abstract June 2015

Hydrophilic vitreous substitute based on cross- linked hyaluronate - assessment of effects on retinal function and intraocular pressure using alternatives to animal testing

Lisa Pohl; Kai Januschowski; Sven Schnichels; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5732.

ARVO Annual Meeting Abstract June 2015

Investigating Retinal Toxicity of a Lutein-Based Dye in a Model of Isolated and Perfused Bovine Retina

Sebastian Mueller; Carlo Krupp; Sven Schnichels; Johanna Hofmann; Martin Stephan Spitzer; Karl Ulrich Bartz-Schmidt; Peter Szurman; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5737.

ARVO Annual Meeting Abstract June 2015

Evaluation of a retinal detachment model for testing hydrophilic vitreous substitute

Nele Schneider; Kai Januschowski; Jose Hurst; Lisa Pohl; Maximilian Schultheiss; Christine Hohenadl; Charlotte Reither; Sven Schnichels; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):378.

ARVO Annual Meeting Abstract June 2015

UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation

Martin Stephan Spitzer; Charlotte Schramm; Tomek Mlynczak Mlynczak; Peter Szurman; Sven Schnichels; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5108.

ARVO Annual Meeting Abstract June 2013

Measuring wearing times of glasses/patches using a well evaluated and safe orthodontic thermosensor device

Kai Januschowski; Till Bechtold; Schott Schott; Maren Huelber-Januschowski; Gunnar Blumenstock; Karl Bartz-Schmidt; Dorothea Besch; Charlotte Schramm

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3989.

ARVO Annual Meeting Abstract June 2013

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Sebastian Mueller; Rebecca Dollinger; Sebastian Thaler; Johanna Hofmann; Martin Spitzer; Karl Bartz-Schmidt; Peter Szurman; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):413.

ARVO Annual Meeting Abstract March 2012

Evaluating Retinal Toxicity of a New Heavy Intraocular Dye Using the Model of Perfused and Isolated Retinal Cultures of Human Origin

Sebastian Mueller; Kai Januschowski; Martin Spitzer; Charlotte Schramm; Karl-Ulrich Bartz-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5373.

ARVO Annual Meeting Abstract March 2012

Effects Of Bevacizumab On Intraocular Pressure Influenced By The Trabecular Meshwork

Kai Januschowski; Charlotte Schramm; Oliver Ottmann; Karl Bartz-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1991.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Alginate- and Hyaluronic Acid–Based Hydrogels as Vitreous Substitutes: An In Vitro Evaluation

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Hyaluronic acid based cross-linked hydrogels – a biosafe, sufficient tamponade of the vitreous body

Pilot Data on Monitoring Objective Compliance with Intermittent Occlusion Glasses Therapy

Efficacy of two different thiol-modified crosslinked hyaluronate formulations compared to silicone oil in a model of retinal detachment

Suprachoroidal hydrogel buckling as a surgical treatment of retinal detachment - biocompatibility and first experiences

Comparison of optic nerve head analysis in patients with glaucomatous optic neuropathy between the simultaneous stereoscopic photography retinal camera (Kowa nonmyd WX3D) and the confocal scanning laser ophthalmoscope (HRT III)

Novel thixotropic silicone oils – the ketchup bottle approach for trocar-guided vitrectomy

Toxic Effects of Melphalan on Retinal Pigment Epithelial Cells

A minimal invasive implantable sensor for telemetric intraocular pressure monitoring

An ex-vivo model for the short term IOP development for vitreous tamponades

Problems in occlusion therapy - a qualitative study with parents and educators

Hydrophilic vitreous substitute based on cross- linked hyaluronate - assessment of effects on retinal function and intraocular pressure using alternatives to animal testing

Investigating Retinal Toxicity of a Lutein-Based Dye in a Model of Isolated and Perfused Bovine Retina

Evaluation of a retinal detachment model for testing hydrophilic vitreous substitute

UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation

Measuring wearing times of glasses/patches using a well evaluated and safe orthodontic thermosensor device

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Evaluating Retinal Toxicity of a New Heavy Intraocular Dye Using the Model of Perfused and Isolated Retinal Cultures of Human Origin

Effects Of Bevacizumab On Intraocular Pressure Influenced By The Trabecular Meshwork

To View More...

You must be signed into an individual account to use this feature.